Hanna Kleczkowska is the Principal Investment Advisor at Helsinn International Services (HIS), an advisory body to the Helsinn Investment Fund. Before joining HIS, she worked for Helsinn Healthcare in the Business Development function, leading a team focusing on new product evaluations for in-licensing or acquisition. Prior to Helsinn, Hanna held senior management positions at Bank Julius Baer and UBS, where she was involved in private and public equity transactions. Hanna started her career at the University of Zurich, Switzerland where she did independent research on the molecular mechanisms of cancer. Later on, at the Ludwig Institute for Cancer Research, she coordinated a cancer biomarker database project.
Hanna holds a PhD in Molecular Biology from University of Warsaw, Poland.